An evidence-based framework for identifying technologies of no or low-added value (NLVT).


Journal

International journal of technology assessment in health care
ISSN: 1471-6348
Titre abrégé: Int J Technol Assess Health Care
Pays: England
ID NLM: 8508113

Informations de publication

Date de publication:
2020
Historique:
pubmed: 14 12 2019
medline: 15 12 2020
entrez: 14 12 2019
Statut: ppublish

Résumé

To synthetize the state of the art of methods for identifying candidate technologies for disinvestment and propose an evidence-based framework for executing this task. An interpretative review was conducted. A systematic literature search was performed to identify secondary or tertiary research related to disinvestment initiatives and/or any type of research that specifically described one or more methods for identifying potential candidates technologies, services, or practices for disinvestment. An iterative and critical analysis of the methods described alongside the disinvestment initiatives was performed. Seventeen systematic reviews on disinvestment or related terms (health technology reassessment or medical reversal) were retrieved and methods of 45 disinvestment initiatives were compared. On the basis of this evidence, we proposed a new framework for identifying these technologies based on the wide definition of evidence provided by Lomas et al. The framework comprises seven basic approaches, eleven triggers and thirteen methods for applying these triggers, which were grouped in embedded and ad hoc methods. Although identification methods have been described in the literature and tested in different contexts, the proliferation of terms and concepts used to describe this process creates considerable confusion. The proposed framework is a rigorous and flexible tool that could guide the implementation of strategies for identifying potential candidates for disinvestment.

Identifiants

pubmed: 31831086
doi: 10.1017/S0266462319000734
pii: S0266462319000734
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

50-57

Auteurs

María Eugenia Esandi (ME)

Departamento de Economía, Universidad Nacional del Sur, Bahia Blanca, Argentina.
Instituto de Investigaciones Epidemiológicas de la Academia Nacional de Medicina de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina.

Iñaki Gutiérrez-Ibarluzea (I)

Osteba, Ministry for Health, Basque Government, Vitoria-Gasteiz, Spain.
BIOEF, Basque Foundation for Health Innovation and Research, Barakaldo, Spain.

Nora Ibargoyen-Roteta (N)

Osteba, Ministry for Health, Basque Government, Vitoria-Gasteiz, Spain.

Brian Godman (B)

Strathclyde Institute of Pharmacy and Biomedical Sciences, Strathclyde University, Glasgow, UK.
Division of Clinical Pharmacology, Karolinska University Hospital Huddinge, Karolinska Institute, Stockholm, Sweden.
Department of Public Health and Pharmacy and Pharmacy Management, School of Pharmacy, Sefako Health Sciences University, Pretoria, South Africa.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH